Neurocrine Biosciences | NBIX - EPS Earnings Per Share

Stock Price
158.42
Daily Change
-0.63 -0.40%
Monthly
23.37%
Yearly
30.90%
Q2 Forecast
155.24

Neurocrine Biosciences reported $1.94 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.94 1.15 0.70 May/05
FY2025Q4 Dec/2025 1.88 1.86 1.69 Feb/11
FY2025Q3 Sep/2025 2.17 1.56 1.81 Oct/28
FY2025Q2 Jun/2025 1.65 0.98 1.63 Jul/30
FY2025Q1 Mar/2025 0.70 0.86 1.20 May/05




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
ALKERMES USD -0.4 0.69 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Exelixis USD 0.87 0.1 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Prothena USD 0.6 1.06 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Repligen USD 0.48 0.01 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026
Xoma USD -1.59 2.43 Sep/2024